Alpine Global Management, LLC Aim Immuno Tech Inc. Transaction History

Alpine Global Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.92 - $1.96 $16,000 - $34,088	-17,392 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$1.91 - $2.17 $2,639 - $2,998	-1,382 Reduced 7.36%	17,392 $36,000
Q3 2021 Nov 12, 2021	BUY	$1.91 - $2.17 $35,858 - $40,739	18,774 New	18,774 $38,000

4.75M

Ticker AIM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,049,300
Market Cap $7.21M
Description
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.